Standard

Risk-taking tendency (4-domain principal component model)

TCF4 · rs72930755

Stands on its own. Nothing else here links to this position yet — but the page above is the point: what the research found, what each genotype means, and where it came from, in language you can read. Links to conditions, drugs and the senses appear automatically if we write them.

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10⁻⁸, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10⁻⁵⁰. 2: ClinVar from one lab (1 star), or p ≤ 10⁻²⁰. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10⁻⁸). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 315,894 European ancestry individuals.

The effect Each copy of the T allele shifted the measure 0.0334 higher (95% confidence interval 0.022-0.045); p = 6 × 10⁻⁹.

How common The T allele had a frequency of about 95% in the people studied.

Where it sits Chromosome 18, band 18q21.2 — in an intron of TCF4.

How common each version is

CT

Korean Korea4K

C 0.1% · T 99.9%

Korean Korea1K

C 0.1% · T 100.0%

Japanese ToMMo

C 0.0% · T 100.0%

World gnomAD

C 4.4% · T 95.6%

World 1000 Genomes

C 2.8% · T 97.2%

World TOPMed

C 4.5% · T 95.5%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study.

What each result means

C/C No copy of the version the research linked to Risk-taking tendency (4-domain principal component model). This is the starting point the study compared everyone against.

C/T One copy of the version the research linked to Risk-taking tendency (4-domain principal component model). That is a smaller link than two copies.

T/T Two copies of the version the research linked to Risk-taking tendency (4-domain principal component model). That is the strongest link of the three results. A link in a study is not a diagnosis.

Source

Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences

Karlsson Linnér R, Biroli P, Kong E, Meddens SFW, Wedow R, Fontana MA, Lebreton M, Tino SP, Abdellaoui A, Hammerschlag AR, Nivard MG, Okbay A

and 80 more — show all

Rietveld CA, Timshel PN, Trzaskowski M, Vlaming R, Zünd CL, Bao Y, Buzdugan L, Caplin AH, Chen CY, Eibich P, Fontanillas P, Gonzalez JR, Joshi PK, Karhunen V, Kleinman A, Levin RZ, Lill CM, Meddens GA, Muntané G, Sanchez-Roige S, Rooij FJV, Taskesen E, Wu Y, Zhang F, Auton A, Boardman JD, Clark DW, Conlin A, Dolan CC, Fischbacher U, Groenen PJF, Harris KM, Hasler G, Hofman A, Ikram MA, Jain S, Karlsson R, Kessler RC, Kooyman M, MacKillop J, Männikkö M, Morcillo-Suarez C, McQueen MB, Schmidt KM, Smart MC, Sutter M, Thurik AR, Uitterlinden AG, White J, Wit H, Yang J, Bertram L, Boomsma DI, Esko T, Fehr E, Hinds DA, Johannesson M, Kumari M, Laibson D, Magnusson PKE, Meyer MN, Navarro A, Palmer AA, Pers TH, Posthuma D, Schunk D, Stein MB, Svento R, Tiemeier H, Timmers PRHJ, Turley P, Ursano RJ, Wagner GG, Wilson JF, Gratten J, Lee JJ, Cesarini D, Benjamin DJ, Koellinger PD, Beauchamp JP

23and Me Research Team · eQTLgen Consortium · International Cannabis Consortium · Social Science Genetic Association Consortium

Nature genetics · 2019 · PMID 30643258

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Risk-taking tendency (4-domain principal component model) (rs72930755). MyGeneLog™. https://www.mygenelog.com/variants/rs72930755

← See all variants